etfmsolutions: VIX XIV Weirdness Resumes....1.15.14

Wednesday, January 15, 2014

VIX XIV Weirdness Resumes....1.15.14

For most of the day both the VIX and its ETF inverse XIV were red....hypothetically an impossible situation.... but it happened. meanwhile the DOW tacked on another 100 points and is likely to cross over the 16,500 line in the sand tomorrow.

Tech (QQQ) and the financials (XLF) considerably outperformed SPY today...you can see it clearly on the Vega model below. I've previously talked about the bullish implications when QQQ and XLF are the momentum leaders and we're clearly in that mode now...can Dow 17,000 be far away?...it could happen in a week if things get rolling with some hot earnings.

M3 continues to be bullish for SPY and QQQ.
FYI....today is the end of the M3 update special offer.

Commentary and Updates

Mosaic Solutions commentary is typically published daily as time permits and market action warrants.
Posts feature Mosaic model updates including delta neutral stops, VIXEN directional trades and PONZO forecasts.

NOTE: Posted risk exposure indicators, signals and metrics apply to Mosaic models only. They are not directly correlated with price movement in the major market indices and can not be used to forecast directional changes in those instruments.
Each Mosaic model is a unique blend of risk factors and must be treated accordingly.

TRENDX is a proprietary Mosaic market signal that blends volume, RSI, momentum and rate of change.

ETF Mosaic Solutions and the editors of Mosaic Solutions are neither an investment advisory service nor registered investment advisers or broker-dealers and do not purport to tell or suggest which securities or currencies readers should buy or sell for themselves.
This site and related software products are for research and educational purposes only, and nothing herein should be construed as an offer to buy or sell, or as a solicitation of an offer to buy or sell securities, or to provide individual investment advice.

Investing is risky and past performance, whether actual or tested, is no guarantee of future results.
Any quantitatively derived allocations referenced herein should only be starting points for conducting your own research.

You are responsible for your own trading decisions and resultant gains or losses. When in doubt, please seek professional guidance from a registered adviser who can respond to your personal needs and risk profile.